Allogeneic BMT significantly contributes to the therapeutic options in children who suffer from refractory or relapsing neoplasms, as well as from chronic bone marrow failure. However, BMT is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback